glutathione platinum resistance

glutathione platinum resistance peroxidase 4‐dependent glutathione high‐consumption drives acquired chemoresistance in lung cancer‐derived brain metastasis - Liu - 2021 - Clinical and Translational Medicine Redox Modulating Formula (RMF) Immunocal Platinum Glutathione Precursor –

Name: glutathione platinum resistance peroxidase 4‐dependent glutathione high‐consumption drives acquired chemoresistance in lung cancer‐derived brain metastasis - Liu - 2021 - Clinical and Translational Medicine Redox Modulating Formula (RMF) Immunocal Platinum Glutathione Precursor –
Brand: www.marsberger-treibhaus.de
SKU: 74102850325
Price: 26.05 USD
Availability: InStock
Rating: 4.7137 (16 reviews)

Immunocal Platinum Glutathione Precursor Advanced Cellular Support with CMP & RMF Immune Support, Antioxidant Defense & Healthy Aging Sugar Free, Lactose Free 30 Servings : Health & Household aisha glutathione Cell intrinsic and tumor microenvironmental determinants of platinum resistance in epithelial ovarian cancer Discover Oncology Decreased Levels of GSH Are Associated with Platinum Resistance in High Grade Serous Ovarian Cancer Platinum resistant ovarian cancer: From mechanisms to treatment strategies PMC

SKU: 74102850325 · From www.marsberger-treibhaus.de

4.7

USD26.05 USD52.05

Pay in 4 interest-free payments of $6.51 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

L-Glutathione, CoQ10, Trans-Resveratrol,European Grapeseed Extract,R-Alpha LipoicAcid,Super Anti-Aging Blend:Pomegranate Juice Powder (fruit) (Punica granatum), Tocotriene Complex, Organic Acai Berry Powder (Euterpe Oleracea) (Freeze-Dried fruit), Pomegranate Extract (fruit) (40% Ellagic Acid), Meriva Turmeric Root Extract (18-22% Curcuminoids & 40% Sunflower-Based Phosphatidyl Choline)

According to the results of a meta-analysis based on fifteen studies enrolling a total of 1633 tumor patients, positive expression of CD44v9 was associated with poor overall survival and relapse-free survival, compared with cancer patients with negative expression of CD44v9 [127]